Japan Animal Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Animal Type (Livestock and Companion), By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines), and Japan Animal Vaccines Market Insights, Industry Trend, Forecasts to 2035

Japan Animal Vaccines Market Insights Forecasts to 2035

• The Japan Animal Vaccines Market Size Was Estimated at USD 545.0 million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 10.36 % from 2025 to 2035
• The Japan Animal Vaccines Market Size is Expected to Reach USD 1611.6 million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Japan Animal Vaccines Market Size is anticipated to Reach USD 1611.6 Million by 2035, Growing at a CAGR of 10.36 % from 2025 to 2035. The animal vaccines market in Japan is driven by various factors, including a rise in livestock population, an increase in cattle disease, rising awareness of animal health and vaccination programs, and technological advancements in vaccine development.

Market Overview

Animal vaccine is also recognized as veterinary vaccines. The Japan animal vaccines market focuses on the development, production, and distribution of vaccines used to prevent infectious diseases in animals. Animal vaccines are biological preparations employed to immunize animals against infectious diseases. They act through the stimulation of an animal's immune system to become immune against a given pathogen, whether a virus or bacteria, without inducing the disease itself. These vaccines are designed for cattle, poultry, swine, dogs and cats, and some aquatic animals. In Japan, the public has become increasingly aware of the need for animal health, which has resulted in higher adoption rates of vaccination programs by owners of pet and livestock animals. Japan's Ministry of Agriculture, Forestry, and Fisheries stated that the number of pet vaccinations had increased by some 25% over the last decade. The rising incidence of swine fever, avian influenza, and rabies, creating demand for preventive vaccinations, is one of the key driving factors in this market in Japan.

Report Coverage

This research report categorizes the market for the Japan animal vaccines market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan animal vaccines market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the japan animal vaccines market.

Driving Factors

The Japan animal vaccines market is experiencing significant growth due to a rise in public awareness about animal health; hence, people are prioritizing preventative care, which boosts the market for animal vaccines in Japan. Japan has tightened up animal health requirements by making vaccinations against certain diseases of animals mandatory. This has enhanced farmer demand and compliance for animal vaccines.  The rising prevalence of zoonotic diseases creates more demand for animal vaccines. Additionally, a rise in the population of livestock and technological advancements positively contribute to the market growth.

Restraining Factors

The prolonged and complex process of animal vaccine approval can delay market entry and contribute to the high cost of development. Additionally, some of the animal vaccines must be stored and shipped in strictly controlled temperatures, which is challenging, further limiting the market expansion.

Market Segmentation

The Japan animal vaccines market share is classified into animal type and product.   

• The livestock segment held the dominant share of the market in 2024 and is expected to grow at a rapid CAGR during the forecast period.   

The Japan animal vaccines market is segmented by animal type into livestock and companion.  Among these, the livestock segment held the dominant share of the market in 2024 and is expected to grow at a rapid CAGR during the forecast period. This is due to the rising livestock population, supportive government initiatives. Additionally, the appearance of illnesses in sheep and cattle contributes to the segmental market growth.

• The attenuated live vaccines segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The Japan animal vaccines market is segmented by product into attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. Among these, the attenuated live vaccines segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because they are cost-effective and offer better immune responses. Additionally, they require less frequent doses and long-lasting immunity.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan animal vaccines market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Kyoritsu Seiyaku
• Nissei ASB Holdings
• Zoetis
• Elanco
• Meiji Animal Health Co., Ltd.
• Nisseiken Co., Ltd.
• PhoenixBio Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan animal vaccines market based on the below-mentioned segments:

Japan Animal Vaccines Market, By Animal Type

• Livestock
• Companion

Japan Animal Vaccines Market, By Product

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines